RS52435B - PROTEAZOMA INHIBITORS - Google Patents

PROTEAZOMA INHIBITORS

Info

Publication number
RS52435B
RS52435B RS20120405A RSP20120405A RS52435B RS 52435 B RS52435 B RS 52435B RS 20120405 A RS20120405 A RS 20120405A RS P20120405 A RSP20120405 A RS P20120405A RS 52435 B RS52435 B RS 52435B
Authority
RS
Serbia
Prior art keywords
proteasome inhibitors
organoboric acid
iprsten
aralkoxy
aryloxy
Prior art date
Application number
RS20120405A
Other languages
English (en)
Serbian (sr)
Inventor
Edward J. Olhava
Miheala D. Danca
Original Assignee
Millennium Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38691782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS52435(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharmaceuticals Inc. filed Critical Millennium Pharmaceuticals Inc.
Publication of RS52435B publication Critical patent/RS52435B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20120405A 2007-08-06 2007-08-06 PROTEAZOMA INHIBITORS RS52435B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07811087A EP2178888B1 (en) 2007-08-06 2007-08-06 Proteasome inhibitors
PCT/US2007/017440 WO2009020448A1 (en) 2007-08-06 2007-08-06 Proteasome inhibitors

Publications (1)

Publication Number Publication Date
RS52435B true RS52435B (en) 2013-02-28

Family

ID=38691782

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120405A RS52435B (en) 2007-08-06 2007-08-06 PROTEAZOMA INHIBITORS

Country Status (33)

Country Link
EP (3) EP3210987A1 (ja)
JP (1) JP5261488B2 (ja)
KR (6) KR20150010802A (ja)
CN (1) CN101772507B (ja)
AU (1) AU2007357338B2 (ja)
BR (1) BRPI0721905B8 (ja)
CA (1) CA2695082C (ja)
CY (2) CY1113386T1 (ja)
DK (1) DK2178888T3 (ja)
EA (1) EA028622B1 (ja)
EC (1) ECSP10010015A (ja)
ES (1) ES2390606T3 (ja)
FR (1) FR17C1011I2 (ja)
GE (1) GEP20125599B (ja)
HK (2) HK1143595A1 (ja)
HR (1) HRP20120745T1 (ja)
HU (1) HUS1700018I1 (ja)
IL (4) IL203641A (ja)
LT (1) LTC2178888I2 (ja)
LU (1) LUC00013I2 (ja)
MY (1) MY161991A (ja)
NL (1) NL300871I2 (ja)
NZ (1) NZ582693A (ja)
PH (1) PH12014500053B1 (ja)
PL (1) PL2178888T3 (ja)
PT (1) PT2178888E (ja)
RS (1) RS52435B (ja)
SG (1) SG10201508712QA (ja)
SI (1) SI2178888T1 (ja)
TN (1) TN2010000060A1 (ja)
UA (1) UA97536C2 (ja)
WO (1) WO2009020448A1 (ja)
ZA (1) ZA201000348B (ja)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
PL1948678T3 (pl) 2005-11-09 2013-09-30 Onyx Therapeutics Inc Związki do hamowania enzymów
DK2041158T3 (da) 2006-06-19 2013-06-24 Onyx Therapeutics Inc Peptid-epoxidketoner til proteasom inhibering
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
KR20150131405A (ko) 2007-10-04 2015-11-24 오닉스 세라퓨틱스, 인크. 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성
KR101690571B1 (ko) 2008-06-17 2016-12-28 밀레니엄 파머슈티컬스 인코퍼레이티드 보로네이트 에스테르 화합물 및 이의 제약학적 조성물
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
EP2349313A4 (en) 2008-10-21 2012-08-29 Onyx Therapeutics Inc COMBINATION THERAPY WITH EPOXYCLETON PEPTIDES
AR075899A1 (es) 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
AU2010341530B2 (en) 2009-12-22 2016-03-10 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
MX2012010017A (es) 2010-03-01 2012-10-01 Onyx Therapeutics Inc Compuestos de para la inhibicion de inmunoproteasomas.
CN102892291A (zh) 2010-03-31 2013-01-23 米伦纽姆医药公司 1-氨基-2-环丙基乙硼酸衍生物
CA2833775A1 (en) * 2011-06-22 2012-12-27 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
HUE060305T2 (hu) * 2011-08-30 2023-02-28 Tufts College FAP-aktivált proteaszóma inhibitorok a szolid tumorok kezelésére
EP2793900B1 (en) * 2011-12-22 2018-08-22 Ares Trading S.A. Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CN104271583B (zh) * 2012-01-24 2017-10-24 米伦纽姆医药公司 治疗鼻咽癌的方法
CA2862492A1 (en) * 2012-01-24 2013-08-01 Millennium Pharmaceuticals, Inc. Methods of treatment of cancer
US20140105921A1 (en) 2012-07-09 2014-04-17 Onyx Therapeutics, Inc. Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
CN109096370B (zh) * 2012-07-26 2022-03-18 圣特莱国际公司 多肽环氧酮化合物
JP2013006855A (ja) * 2012-09-03 2013-01-10 Millennium Pharmaceuticals Inc プロテアソーム阻害剤
ES2615744T3 (es) * 2012-12-03 2017-06-08 F. Hoffmann-La Roche Ag Compuestos de ácido triazol-borónico sustituidos
CN105705149A (zh) * 2013-10-03 2016-06-22 米伦纽姆医药公司 用于预防或治疗系统性红斑狼疮和/或狼疮性肾炎的方法
KR102481856B1 (ko) 2014-05-20 2022-12-26 밀레니엄 파머슈티컬스 인코퍼레이티드 일차 암 치료법 후 사용하기 위한 붕소-함유 프로테아좀 저해제
WO2016022955A1 (en) 2014-08-07 2016-02-11 Mayo Foundation For Medical Education And Research Compounds and methods for treating cancer
MA41555A (fr) * 2015-02-17 2017-12-26 Millennium Pharm Inc Polythérapie pour le traitement du cancer
WO2016205790A2 (en) 2015-06-19 2016-12-22 Hanlin Scientific, Inc. Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
CN106608883A (zh) * 2015-10-21 2017-05-03 北京大学 蛋白酶体抑制剂mln9708的合成方法
CN107400142B (zh) * 2016-05-19 2019-11-19 成都奥璟生物科技有限公司 一种硼酸和硼酸酯类化合物及其应用
CN106008572B (zh) * 2016-05-23 2018-08-17 成都千禧莱医药科技有限公司 一类二肽硼酸化合物及制备方法和用途
CN114685453A (zh) 2016-06-21 2022-07-01 奥瑞恩眼科有限责任公司 杂环脯氨酰胺衍生物
JP7164521B2 (ja) 2016-06-21 2022-11-01 オリオン・オフサルモロジー・エルエルシー 炭素環式プロリンアミド誘導体
US10995103B2 (en) 2016-07-25 2021-05-04 Shenzhen Targetrx, Inc. Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
CN108440583B (zh) * 2017-01-23 2020-12-04 成都奥璟生物科技有限公司 一种新的硼酸衍生物及其药物组合物
WO2018160717A1 (en) 2017-02-28 2018-09-07 Mayo Foundation For Medical Education And Research Compounds and methods for treating cancer
CN108794516A (zh) * 2017-04-26 2018-11-13 上海时莱生物技术有限公司 硼酸和硼酸酯类化合物及其制备方法和用途
WO2019020099A1 (zh) * 2017-07-28 2019-01-31 成都地奥九泓制药厂 一种硼酸酯化合物、其合成方法及其用途
WO2019038406A1 (en) 2017-08-25 2019-02-28 Synthon B.V. PROCESS FOR THE PREPARATION OF IXAZOMIB OR ITS INTERMEDIATES
JP2018024694A (ja) * 2017-10-03 2018-02-15 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
US11243207B2 (en) 2018-03-29 2022-02-08 Mayo Foundation For Medical Education And Research Assessing and treating cancer
CN110903310B (zh) * 2018-09-14 2022-11-22 成都奥璟生物科技有限公司 一种硼酸酯类药物及其用途
CN110357787A (zh) * 2019-08-02 2019-10-22 苏州艾和医药科技有限公司 依沙佐米合成工艺研究
WO2021071932A1 (en) * 2019-10-07 2021-04-15 Cornell University Antimicrobial and antiviral effects of c2-c7alkyl boronic acids
CN110950897B (zh) * 2019-12-12 2021-05-28 山东大学 一种组蛋白去乙酰化酶、蛋白酶体双靶点抑制剂及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2435146C (en) * 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
ATE317850T1 (de) 2001-05-30 2006-03-15 Novartis Pharma Gmbh 2-((n-(2-amino-3-(heteroaryl- oder - aryl)propionyl)aminoacyl)amino)- alkylboronsäurederivate
CN1867572B (zh) * 2003-08-14 2012-03-28 赛福伦公司 蛋白酶体抑制剂及其使用方法
US7576206B2 (en) * 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
PT2377869E (pt) 2004-03-30 2014-04-15 Millennium Pharm Inc Síntese de bortezomib
WO2006008660A2 (en) 2004-07-20 2006-01-26 Affinium Pharmaceuticals, Inc. Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk)
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
GB0513349D0 (en) 2005-06-29 2005-08-03 Torres Manel Non-woven fabric
JP5229897B2 (ja) 2005-07-05 2013-07-03 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ 線維芽細胞活性化タンパクα阻害剤

Also Published As

Publication number Publication date
ZA201000348B (en) 2011-03-30
AU2007357338A1 (en) 2009-02-12
LTPA2017010I1 (lt) 2017-05-10
WO2009020448A1 (en) 2009-02-12
SI2178888T1 (sl) 2012-11-30
IL203641A (en) 2015-11-30
IL242291A0 (en) 2015-11-30
KR20170004031A (ko) 2017-01-10
FR17C1011I2 (fr) 2018-04-27
BRPI0721905B8 (pt) 2021-05-25
AU2007357338B2 (en) 2014-03-20
IL242290A (en) 2017-12-31
EA201070247A1 (ru) 2010-06-30
CY2017016I2 (el) 2017-07-12
PH12014500053A1 (en) 2015-03-30
NL300871I2 (nl) 2017-12-07
EP2527347A1 (en) 2012-11-28
EP2178888A1 (en) 2010-04-28
FR17C1011I1 (ja) 2017-05-26
KR101831674B1 (ko) 2018-02-23
UA97536C2 (en) 2012-02-27
HK1143595A1 (en) 2011-01-07
HK1182924A1 (zh) 2013-12-13
IL242292A (en) 2017-12-31
EP3210987A1 (en) 2017-08-30
BRPI0721905B1 (pt) 2020-11-17
CY2017016I1 (el) 2017-07-12
CA2695082C (en) 2015-07-28
CN101772507A (zh) 2010-07-07
JP5261488B2 (ja) 2013-08-14
KR20140042932A (ko) 2014-04-07
TN2010000060A1 (en) 2011-09-26
LTC2178888I2 (lt) 2018-03-12
PH12014500053B1 (en) 2015-03-30
MY161991A (en) 2017-05-31
CN101772507B (zh) 2012-12-12
KR20160040735A (ko) 2016-04-14
CY1113386T1 (el) 2016-06-22
DK2178888T3 (da) 2012-10-01
BRPI0721905A2 (pt) 2014-02-25
HRP20120745T1 (hr) 2012-10-31
NZ582693A (en) 2012-01-12
LUC00013I2 (ja) 2017-06-19
IL242291A (en) 2017-12-31
PL2178888T3 (pl) 2012-11-30
HUS1700018I1 (hu) 2017-05-29
KR101474831B1 (ko) 2014-12-19
EA028622B1 (ru) 2017-12-29
ES2390606T3 (es) 2012-11-14
JP2010535759A (ja) 2010-11-25
SG10201508712QA (en) 2015-11-27
EP2178888B1 (en) 2012-07-04
PT2178888E (pt) 2012-10-04
KR20150010802A (ko) 2015-01-28
KR20140042933A (ko) 2014-04-07
GEP20125599B (en) 2012-08-10
IL242290A0 (en) 2015-11-30
ECSP10010015A (es) 2010-04-30
CA2695082A1 (en) 2009-02-12
KR20100059811A (ko) 2010-06-04
LUC00013I1 (ja) 2017-04-06
IL242292A0 (en) 2015-11-30

Similar Documents

Publication Publication Date Title
RS52435B (en) PROTEAZOMA INHIBITORS
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
RS54587B1 (en) IMINOTIADIAZINE-DIOXIDE COMPOUNDS AS BACE, MIXTURE, AND USE INHIBITORS
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
RS52323B (en) 2'-FLUORO-2'-DEOKSITETRAHIDROURIDINI KAO INHIBITORI CITIDIN DEAMINAZE
MY148634A (en) Pyridazinone derivatives
WO2008016522A3 (en) Hiv reverse transcriptase inhibitors
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
RS51970B (en) TRICYCLIC UNITS AND THEIR USE AS MODULATORS OF GLUCOCORTICOID RECEPTORS
RS54386B1 (en) ANTIVIRAL UNITS
MX2009013804A (es) Inhibidores novedosos de transcriptasa inversa de vih.
RS53301B (en) TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES
TNSN08407A1 (en) Organic compounds
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
TW200640913A (en) 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
MX2009008506A (es) Derivados del pirazol como inhibidores de 11-b-hsd1.
HRP20080027T3 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
RS53152B (en) NEW ANTIBACTERIAL AGENTS FOR TREATMENT OF Gram POSITIVE INFECTIONS
SG170049A1 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
DE602004026903D1 (de) P-glycoprotein-inhibitor, verfahren zu dessen hersiesen enthält